 |
 |
|
 |
 |
 |
IQuum to Exhibit Liat™ Systems at the AMP 2005 Annual Meeting and Exhibit Allston, MA, October 14, 2005 -- IQuum announced that it will showcase the Liat™ Analyzer and the Liat FlowCycler™ at the Association for Molecular Pathology (AMP) 2005 Annual Meeting. This year, the AMP exhibit will be held at the Westin Kierland Resort & Spa, Scottsdale, Arizona, from November 11 to November 12. IQuum will be located at booth #310. Fulfilling a long standing industry need for easy-to-use, rapid, and sensitive automation for molecular diagnostics, the Liat Analyzer refines nucleic acid testing to three simple steps: collecting a raw biological sample such as whole blood into a Liat Tube, scanning the tube's barcode, and inserting the tube into the Liat Analyzer. Using the reagents pre-packed in the Liat Tube, the Analyzer automatically executes all the required assay steps, including sample preparation, target enrichment, inhibitor removal, nucleic acid extraction, amplification and real-time detection, and reports quantitative test results on the built-in touch screen in as little as 30 minutes. Most assays, including those for infectious disease, can be completed in around 1 hour. Built on the same innovative lab-in-a-tube platform, the Liat FlowCycler is designed for multi-sample rapid PCR thermal cycling. Utilizing flow cycling rather than thermal block ramping, the FlowCycler can complete 30 cycles on a 50µl reaction in as little as 7 minutes, significantly faster then other commercially available thermal cyclers. In addition, the FlowCycler can process up to 48 or 96 samples concurrently in its 2 independent bays. Together, the Liat FlowCycler and the Liat Analyzer will allow users to perform both high throughput and random access nucleic acid testing on a uniform platform, thereby streamlining clinical testing. IQuum’s Liat technology is protected by US Patent 6,780,617, European Patent No. EP1,347,833 and other patents and patent applications. About AMP The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the then-emerging field of molecular diagnostics. Through its Council and Committees, AMP pursues topics of importance to those at the forefront of this growing discipline. From the beginning, AMP has worked to develop mechanisms for training and certification in diagnostic molecular pathology. AMP has assumed national visibility with its efforts to shape regulations and policy that influence research and the practice of molecular diagnostics. The organization is divided into the scientific subdivisions of genetics, infectious diseases, hematopathology, and solid tumors. Each subdivision addresses issues, identifies goals, shapes policy, and provides member benefits specific to that particular discipline. Members can participate in any or all of these subdivisions. The AMP membership includes individuals from academia, government, and industry, including basic scientists, laboratory directors, medical technologists, and trainees. Through the efforts of an enthusiastic membership from across the United States and around the world, AMP continues to grow in numbers and influence. About IQuum, Inc.IQuum is a leader in developing lab-in-a-tube technology, a novel biological sample testing platform intended to provide revolutionary benefits to a broad cross section of the bioassay market. The Company's proprietary technology will enable the less experienced professional to perform more sophisticated biological sample testing in a less expensive setting with greater speed. The lab-in-a-tube platform is the foundation of next generation tools for clinical diagnostics, biodefense, and industrial testing. Founded in 1998, IQuum is located in the Boston metropolitan area in Massachusetts. For more information, please visit www.IQuum.com.
|